Luigia Venegoni Selected Research

Luigia Venegoni Research Topics

6	Neoplasms (Cancer) 03/2024 - 06/2008
2	Mycosis Fungoides 11/2023 - 11/2021
2	Disease Progression 01/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Bullous Pemphigoid (Pemphigoid) 12/2020 - 01/2015
2	Chronic Urticaria 01/2015 - 01/2009
1	Skin Manifestations 01/2023
1	COVID-19 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	Lymphomatoid Papulosis 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Cicatrix (Scar) 12/2020
1	Merkel Cell Carcinoma 08/2020
1	Nevus (Nevi) 01/2019
1	Linear IgA Bullous Dermatosis 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2008
1	Pemphigus (Pemphigus Vulgaris) 01/2007

4	AutoantibodiesIBA 12/2020 - 01/2007
2	ruxolitinibIBA 01/2022 - 01/2018
2	NestinIBA 01/2021 - 01/2019
2	Adapalene (Differin)FDA LinkGeneric 01/2021 - 08/2020
2	Thromboplastin (Tissue Factor)IBA 01/2015 - 01/2009
2	Monoclonal AntibodiesIBA 06/2008 - 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	dupilumabIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	CytokinesIBA 01/2023
1	ChromatinIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021
1	Formaldehyde (Formol)FDA Link 11/2021
1	ParaffinIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2020
1	AntigensIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Janus Kinase 2IBA 01/2018
1	Etanercept (Enbrel)FDA Link 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2015
1	Prothrombin (Factor II)IBA 01/2015
1	AnticoagulantsIBA 01/2015
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2009
1	Keratins (Keratin)IBA 06/2008
1	Rituximab (Mabthera)FDA Link 01/2007
1	CD20 AntigensIBA 01/2007
1	DesmogleinsIBA 01/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2007

2	Therapeutics 01/2022 - 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 08/2009